Yagi, Ryuichiro
Goto, Shinichi http://orcid.org/0000-0002-0450-0331
Himeno, Yukihiro
Katsumata, Yoshinori
Hashimoto, Masahiro
MacRae, Calum A. http://orcid.org/0000-0001-5181-2664
Deo, Rahul C. http://orcid.org/0000-0002-2791-9434
Funding for this research was provided by:
American Heart Association (One Brave Idea, One Brave Idea, One Brave Idea)
Article History
Received: 21 March 2023
Accepted: 2 February 2024
First Online: 21 March 2024
Competing interests
: R.C.D. has received consulting fees from Novartis and Pfizer, and is co-founder of Atman Health. C.A.M. has received consulting fees from Foresite Labs, Clarify Health, Bayer, BioSymetrics, Dinaqor, Janssen, Affinia, Dewpoint Therapeutics, and Pfizer and is a co-founder of Atman Health. The other authors declare no competing interests.